Materias dentro de su búsqueda.
Mostrando 941 - 960 Resultados de 4,357 Para Buscar '"health economics"', tiempo de consulta: 0.31s Limitar resultados
  1. 941
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review
  2. 942
    “…DMT costs reduced over the same period. CONCLUSION: Health economic and clinical benefits were seen following switching to alemtuzumab from other DMTs for treatment of MS, in this cohort from the USA.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health economic outcomes of switching to alemtuzumab from other disease-modifying therapies in people with multiple sclerosis in the USA
  3. 943
    “…PURPOSE: A systematic literature review was conducted to (1) summarize the current health economic evidence for LB assays and (2) identify and analyze the studies addressed or reported on the challenges of health economic modeling in precision medicine. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review
  4. 944
    “…OBJECTIVE: To investigate the cost-effectiveness of using Implant Movement Analysis (IMA) to follow up suspected aseptic loosening when the diagnosis after an initial X-ray is not conclusive, compared with a diagnostic pathway with X-ray follow-up. METHODS: A health-economic model in the form of a decision tree was developed using quality-adjusted life years (QALY) from the literature, cost-per-patient data from a university hospital and the probabilities of different events from expert physicians’ opinions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model
  5. 945
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Review of Australian health economic evaluation – 245 interventions: what can we say about cost effectiveness?
  6. 946
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK
  7. 947
    “…BACKGROUND: The purpose of the analysis was to develop a health economic model to estimate the costs and health benefits of alternative National Health Service (NHS) service configurations for people with longer-term depression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community
  8. 948
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
  9. 949
    por Schwander, Bjoern
    Publicado 2014
    “…In these scenario analyses a strong variation of the cost-effectiveness results was obtained ranging from €23,512 (best case) to €176,958 (worst case) per QALY gained by AVD therapy. This early health economic evaluation has to handle with three main uncertainty factors: the effect size of next generation AVDs, the costs of next generation AVDs and the WTP threshold that might be applied in RP patients, which reflect the main limitations of the presented assessment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany
  10. 950
    “…BACKGROUND: A trade-off exists between building confidence in health-economic (HE) decision models and the use of scarce resources. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users
  11. 951
    “…The Expected Value of Perfect Partial Information (EVPPI) is a decision‐theoretic measure of the ‘cost’ of parametric uncertainty in decision making used principally in health economic decision making. Despite this decision‐theoretic grounding, the uptake of EVPPI calculations in practice has been slow. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation
  12. 952
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis
  13. 953
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model
  14. 954
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model
  15. 955
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort
  16. 956
    “…The approaches were compared based on point-estimates and distributions of time-to-event and health economic outcomes. To assess sample size impact on the uncertainty in these outcomes, sample size was varied in the simulation study and subgroup analyses were performed for the case-study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models
  17. 957
    “…CONCLUSION: Privately insured US patients with schizophrenia experience a substantial clinical and health economic burden related to comorbidities, acute care needs, nonadherence, and polypharmacy and have relatively low use of LAIs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
  18. 958
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model
  19. 959
    “…CONCLUSIONS: STEPP provides a systematic approach to assess the interaction between baseline risk and the difference in NMB between competing interventions and to identify cutoffs to stratify patients in a health economically optimal manner.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
  20. 960
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Heterogeneity of cost estimates in health economic evaluation research. A systematic review of stress urinary incontinence studies
Herramientas de búsqueda: RSS